(Q41466880)

1 October 2017

Safety and efficacy of chronic therapy with captopril in hypertensive patients: an update (English)

1 reference

1 October 2017

Waeber B

1

1 reference

1 October 2017

Gavras I

series ordinal

2

1 reference

1 October 2017

Brunner HR

series ordinal

3

1 reference

1 October 2017

Gavras H

series ordinal

4

1 reference

1 October 2017

1 November 1981

1 reference

The Journal of Clinical Pharmacology

1 October 2017

1 reference

1 October 2017

21

1 reference

1 October 2017

11-12 Pt 1

1 reference

1 October 2017

508-516

1 reference

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1981.TB05658.X

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1981.TB05658.X

Effect of Captopril on Renal Vascular Tone in Patients with Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1981.TB05658.X

Increased Glomerular Filtration Rate after Converting-Enzyme Inhibition in Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1981.TB05658.X

Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1981.TB05658.X

Pemphigus foliaceus induced by penicillamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1981.TB05658.X

10.1002/J.1552-4604.1981.TB05658.X

21 January 2018

Identifiers

DOI

1 reference

1 October 2017

1 reference